+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Topical Hemostat Market by Product (Collagen-Based Topical Hemostats, Combination Topical Hemostats, Gelatin-Based Topical Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application, End-Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 195 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 4989882
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Topical Hemostat Market grew from USD 2.12 billion in 2023 to USD 2.26 billion in 2024. It is expected to continue growing at a CAGR of 6.80%, reaching USD 3.36 billion by 2030.

It is applied directly to a wound or surgical site to prevent excessive blood loss and to encourage clot formation. Topical hemostats are used in various medical situations, from emergency settings and surgical procedures to managing chronic wounds. Topical hemostats contain active substances that accelerate the body's natural clotting process or provide a physical barrier to assist with blood containment. A global rise in surgeries due to an aging population and the elevating incidences of chronic diseases is driving the market. However, the high cost of advanced hemostats and potential complications associated with using certain hemostatic agents can restrict their application and limit their accessibility. Nevertheless, the development of synthetic and bioactive materials that can mimic natural hemostasis and the utilization of nanotechnology in developing advanced hemostatic agents are expected to create lucrative opportunities for the topical hemostat market.

Regional Insights

The Americas exhibit robust growth in the topical hemostat market supported by healthcare infrastructure, high per capita healthcare expenditure, and a focus on advanced surgical procedures. Furthermore, the consumer need, due to the prevalence of surgical procedures and advanced wound management practices with high awareness of the effectiveness of topical hemostats and the readiness of healthcare providers to adopt new technologies, bolster the market growth. Recent investments are primarily channeled toward developing advanced biocompatible and biodegradable hemostats in the Americas. The European Union boasts a sophisticated healthcare system with a strong emphasis on patient safety and high standards of care, which drives the demand for topical hemostats in Europe. The presence of major pharmaceutical companies, coupled with significant investments in research, creates a favorable environment for market growth. On the other hand, in the Middle East and Africa, the market is growing owing to consumers' awareness of advanced medical products and rising demand linked to the development of healthcare infrastructure and the private healthcare sector. Investments and initiatives in these regions focus on capacity building in healthcare services, including adopting effective surgical aids such as topical hemostats. The Asia Pacific region presents a diverse and rapidly expanding topical hemostat market owing to its sizeable populations, growing economies, and investment in healthcare innovation. Furthermore, government backing and a focus on self-sufficiency in healthcare technologies have spurred market growth, leading to a surge in local manufacturing and innovation. The latest patents in the APAC region reflect a drive towards developing innovative hemostatic agents suitable for the local market, considering the economic and healthcare delivery constraints.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Topical Hemostat Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Rising numbers of surgeries due to an aging population and prevalence of chronic diseases
  • Favorable product approval by medical regulators

Market Restraints

  • High costs associated with topical hemostat products

Market Opportunities

  • Ongoing R&D for the introduction of novel topical hemostat
  • Integration of nanotechnology to create more efficient topical hemostats

Market Challenges

  • Operational limitations and risk of infection associated with the use of topical hemostats

Market Segmentation Analysis

  • Product: Burgeoning adoption of combination topical hemostats owing to the additional benefits such as infection reduction
  • Formulation: Proliferating utilization of matrix and gel hemostats owing to their ability to conform to irregular wound surfaces
  • Application: Significant usage of topical hemostats in cardiovascular surgery
  • End-Use: Evolving utilization of topical hemostats in hospitals

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Topical Hemostat Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Topical Hemostat Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Ethicon Introduces ETHIZIA Hemostatic Sealing Patch, Clinically Proven to Stop Disruptive Bleeding

Ethicon, a provider in medical devices and a member of the Johnson & Johnson Medical Devices Companies, announced the launch of the ETHIZIA Hemostatic Sealing Patch. The patch represents advancing patient care and improving surgical outcomes. The introduction of the ETHIZIA patch is poised to revolutionize the topical hemostat market by providing surgeons with a potent tool for managing challenging bleeding scenarios, thus reinforcing Ethicon's commitment to enhancing surgical proficiency and patient well-being.

Medcura Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat

Medcura, Inc., an innovator in medical device technology, achieved a significant milestone by receiving the prestigious Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for their pioneering LifeGel Absorbable Surgical Hemostat. The FDA's Devices Program accelerates the development of promising technologies that provide enhanced treatment options for life threatening or severely debilitating conditions.

Hemostasis Closes Acquisition of Fiagon Medical Technologies

Hemostasis LLC acquired Fiagon Medical Technologies, a transaction that underscores Hemostasis's commitment to driving innovation and expansion in the field of surgical care solutions. The strategic alignment of Hemostasis's manufacturing prowess with Fiagon's cutting-edge technology is anticipated to result in enhanced product offerings, ultimately benefiting patients and healthcare providers alike.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Topical Hemostat Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Topical Hemostat Market, highlighting leading vendors and their innovative profiles. These include Aegis Lifesciences Private Limited, Axio Biosolutions Pvt Ltd, B.Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Betatech Medical, BioCer Entwicklungs-GmbH, Bristol-Myers Squibb Company, Dilon Technologies Inc, GELITA MEDICAL GmbH, Hemostasis, LLC, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Marine Polymer Technologies, Inc., Medline Industries, LP, Medtrade Products Ltd, Medtronic PLC, Meril Life Sciences Pvt. Ltd, Pfizer Inc., Southmedic Inc., Stryker Corporation, SYMATESE SAS, Takeda Pharmaceutical Company Limited, Teleflex Incorporated, and Zeria Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Topical Hemostat Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

  • Collagen-Based Topical Hemostats
  • Combination Topical Hemostats
  • Gelatin-Based Topical Hemostats
  • Oxidized Regenerated Cellulose-based Topical Hemostats
  • Thrombin-Based Topical Hemostats

Formulation

  • Matrix & Gel Hemostats
  • Powder Hemostats
  • Sheet & Pad Hemostats
  • Sponge Hemostats

Application

  • Cardiovascular Surgery
  • General Surgery
  • Liver & Spleen Lacerations
  • Orthopedic Surgery
  • Reconstructive Surgery

End-Use

  • Hospitals
  • Nursing Homes
  • Surgical Centers

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising numbers of surgeries due to an aging population and prevalence of chronic diseases
5.1.1.2. Favorable product approval by medical regulators
5.1.2. Restraints
5.1.2.1. High costs associated with topical hemostat products
5.1.3. Opportunities
5.1.3.1. Ongoing R&D for the introduction of novel topical hemostat
5.1.3.2. Integration of nanotechnology to create more efficient topical hemostats
5.1.4. Challenges
5.1.4.1. Operational limitations and risk of infection associated with the use of topical hemostats
5.2. Market Segmentation Analysis
5.2.1. Product: Burgeoning adoption of combination topical hemostats owing to the additional benefits such as infection reduction
5.2.2. Formulation: Proliferating utilization of matrix and gel hemostats owing to their ability to conform to irregular wound surfaces
5.2.3. Application: Significant usage of topical hemostats in cardiovascular surgery
5.2.4. End-Use: Evolving utilization of topical hemostats in hospitals
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Topical Hemostat Market, by Product
6.1. Introduction
6.2. Collagen-Based Topical Hemostats
6.3. Combination Topical Hemostats
6.4. Gelatin-Based Topical Hemostats
6.5. Oxidized Regenerated Cellulose-based Topical Hemostats
6.6. Thrombin-Based Topical Hemostats
7. Topical Hemostat Market, by Formulation
7.1. Introduction
7.2. Matrix & Gel Hemostats
7.3. Powder Hemostats
7.4. Sheet & Pad Hemostats
7.5. Sponge Hemostats
8. Topical Hemostat Market, by Application
8.1. Introduction
8.2. Cardiovascular Surgery
8.3. General Surgery
8.4. Liver & Spleen Lacerations
8.5. Orthopedic Surgery
8.6. Reconstructive Surgery
9. Topical Hemostat Market, by End-Use
9.1. Introduction
9.2. Hospitals
9.3. Nursing Homes
9.4. Surgical Centers
10. Americas Topical Hemostat Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Topical Hemostat Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Topical Hemostat Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Ethicon Introduces ETHIZIA Hemostatic Sealing Patch, Clinically Proven to Stop Disruptive Bleeding
13.3.2. Medcura Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat
13.3.3. Hemostasis Closes Acquisition of Fiagon Medical Technologies
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. TOPICAL HEMOSTAT MARKET RESEARCH PROCESS
FIGURE 2. TOPICAL HEMOSTAT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. TOPICAL HEMOSTAT MARKET DYNAMICS
FIGURE 7. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 14. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. TOPICAL HEMOSTAT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED TOPICAL HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION TOPICAL HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION TOPICAL HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED TOPICAL HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED TOPICAL HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED TOPICAL HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY LIVER & SPLEEN LACERATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY LIVER & SPLEEN LACERATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NURSING HOMES, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 75. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 76. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 77. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 78. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 79. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 82. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 83. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 84. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 85. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 86. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 87. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 90. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 93. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 94. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 95. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 98. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 99. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 100. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 104. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 108. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 110. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 111. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 112. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 113. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 114. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 115. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 118. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 119. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 122. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 123. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 126. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 127. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 128. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 129. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 130. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 131. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 134. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 135. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 136. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 137. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 138. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 139. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 142. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 143. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 146. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 147. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 150. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 151. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 152. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 153. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 154. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 155. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 158. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 159. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 160. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 161. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 162. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 163. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 166. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 167. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 168. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 169. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 170. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 171. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 174. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 175. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 176. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 177. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 178. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 179. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 182. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 183. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 184. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 185. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 186. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 187. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 190. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 191. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 192. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 193. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 194. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 195. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 198. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 199. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 200. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 201. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 202. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 203. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 206. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 217. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 218. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 219. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 220. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 221. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 224. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 225. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 226. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 227. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 228. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 229. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 232. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 233. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 234. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 235. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 236. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 237. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 238. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 239. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 240. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 241. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 244. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 245. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 248. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 249. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 250. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 251. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 252. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 253. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 256. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 257. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 258. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 259. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 260. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 261. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 262. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 263. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 264. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 265. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 268. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 269. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 272. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 273. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 274. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 275. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 276. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 277. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 280. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 281. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 282. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 283. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 284. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 285. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 286. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 287. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 288. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 289. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 290. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 291. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 292. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 293. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 294. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 295. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 296. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 297. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 298. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 299. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 300. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 301. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 302. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 303. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 304. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 305. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 306. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 307. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 308. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 309. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 310. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 311. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 312. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 313. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 314. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 315. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 316. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 317. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 318. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 319. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 320. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 322. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 324. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 326. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 328. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 330. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 332. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 333. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 334. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 335. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 336. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 337. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 338. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 339. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 340. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 341. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 342. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 343. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 344. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 345. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 346. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 347. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 348. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 349. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 350. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 351. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 352. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 353. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 354. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 355. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 356. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 357. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 358. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 359. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 360. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 361. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 362. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 363. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 364. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 365. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLIO

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aegis Lifesciences Private Limited
  • Axio Biosolutions Pvt Ltd
  • B.Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Betatech Medical
  • BioCer Entwicklungs-GmbH
  • Bristol-Myers Squibb Company
  • Dilon Technologies Inc
  • GELITA MEDICAL GmbH
  • Hemostasis, LLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Marine Polymer Technologies, Inc.
  • Medline Industries, LP
  • Medtrade Products Ltd
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd
  • Pfizer Inc.
  • Southmedic Inc.
  • Stryker Corporation
  • SYMATESE SAS
  • Takeda Pharmaceutical Company Limited
  • Teleflex Incorporated
  • Zeria Pharmaceutical Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.26 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.36 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal

Related Topics

Related Reports

Hemostats Market, By Type, By Formulation, By Application, By End User, By Distribution Channel: By Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024-2032 - Product Image

Hemostats Market, By Type, By Formulation, By Application, By End User, By Distribution Channel: By Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024-2032

  • Report
  • 277 Pages
  • Global
From
Hemostats and Tissue Sealants Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030 - Product Image

Hemostats and Tissue Sealants Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report
  • 255 Pages
  • Global
From
Hemostats and Tissue Sealants - Global Strategic Business Report - Product Image

Hemostats and Tissue Sealants - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Topical Absorbable Hemostats Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 - Product Image

Topical Absorbable Hemostats Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

  • Report
  • Global
From
Hemostats Global Market Report 2024 - Product Image

Hemostats Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From

About the Topical Hemostat Market

In the field of wound care, the Topical Hemostat market encompasses a range of products designed to promote hemostasis, which is the process of blood clot formation to stop bleeding. These products are particularly crucial in surgical procedures, trauma situations, and in treating individuals with clotting deficiencies. Topical hemostats are available in various forms, including granular powders, films, pads, and gels. They work by different mechanisms; some provide a physical barrier to bleeding, while others promote the aggregation of platelets or catalyze the clotting process through biological or synthetic materials. The choice of topical hemostat may depend on factors such as the nature and location of the wound, the extent of bleeding, and any underlying patient conditions. With ongoing research and development, the market has seen the introduction of more advanced hemostatic agents that offer improved efficacy, faster action, and greater biocompatibility. Several companies are prominent in the Topical Hemostat market, maintaining a strong presence in the wound care sector. Notable players include Johnson & Johnson (with its ETHICON subsidiary), Baxter International Inc., Becton, Dickinson and Company (BD), CryoLife Inc., Pfizer Inc., and Z-Medica, LLC. These companies engage in the development, manufacturing, and distribution of hemostatic products, and often invest in research to advance the field of topical hemostasis further. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.